8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-21-022069
Material agreement · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading xfor-20211105.htm…